Products - Genomic biomarker-based cancer treatments | Topic | NICE

Showing 1 product

Date | Title

Status: PublishedRemove ‘Status: Published’ filter

Larotrectinib for treating NTRK fusion-positive solid tumours (TA630)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
27 May 2020